‘A viral Facebook post nearly blew up our business’
Joanna Jensen, founder of skincare brand Childs Farm, shares advice for start-ups for our CEO Secrets series.
Similar Posts
Nine months after scandal, publishers are still sorting out a plagiarism mess
This week, Simon & Schuster finally published “The Book of Animal Secrets: Nature’s Lessons for a Long and Happy Life,” the highly anticipated book by USC’s Dr. David Agus whose release was suspended after the manuscript was found to contain numerous instances of plagiarism. The new version of the book differs subtly from the one…
Austria stalls Russian sanctions over Raiffeisen blacklisting | Reuters News Agency
Business & FinanceGovernment 14 December 2023, 5:25 am 1 minute Reuters exclusively reported that Austria is seeking to have Raiffeisen Bank International, the biggest Western bank in Russia, struck off a Ukrainian blacklist in return for signing off fresh European Union sanctions on Russia, said two people familiar with the situation. Market Impact Raiffeisen’s presence…
Zhongzhi Enterprise Group: Chinese shadow bank files for bankruptcy
The troubled firm reportedly told investors in November its liabilities had outstripped its assets.
Remote Work Culture: Lessons from Countries That Mastered It Early
When the pandemic forced much of the world into remote work, many businesses scrambled to adopt policies, tools, and cultural shifts that could support employees outside the office. But for some countries, this wasn’t new territory. They had already experimented with flexible work arrangements, digital infrastructure, and employee well-being programs long before 2020. Now, as…
So you want to be a social media star? Here’s how to make money as an influencer in 2024
Half a trillion dollars. That’s how large the creator economy, currently pegged at $250 billion, is predicted to grow in the next four years, according to Goldman Sachs. While people have been making a living off of creating content for online audiences for nearly two decades, what was once a nascent industry is growing up….
Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx for $28 each was expected have a value of $1.9 billion net of estimated cash required. Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved….
